Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
Xenofon Baraliakos, Mikkel Østergaard, Lianne S. Gensler, Denis Poddubnyy, Eun Young Lee, Uta Kiltz, Ruvie Martin, Hiroshi Sawata, Aimee Readie, Brian Porter, the SURPASS Study Group
Topics & Concepts
MedicineBiosimilarSecukinumabAnkylosing spondylitisAdalimumabPharmacotherapySpondylitisDermatologyInternal medicineRheumatoid arthritisPsoriatic arthritisSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesSpine and Intervertebral Disc Pathology